CIAM
SER icon

Caitong International Asset Management’s Serina Therapeutics SER Stock Holding History

Caitong International Asset Management’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.26K Sell
3,744
-238
-6% -$447 ﹤0.01% 1225
2026
Q1 		$7.72K Buy
+3,982
New +$8.77K ﹤0.01% 1103

Other funds holding SER

SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WA
Waverly Advisors Birmingham, Alabama $17.2B AUM 24.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KP
Keel Point Huntsville, Alabama $1.69B AUM 20.79% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Caitong International Asset Management's SER Position: Q2 2026 in Review

Caitong International Asset Management reduced its Serina Therapeutics (SER) stake by 6% in Q2 2026, selling an estimated $447 and leaving 3,744 shares worth $7.26K. The position accounts for ﹤0.01% of the portfolio, ranked #1225.

Caitong International Asset Management first reported a position in SER in Q1 2026 and has held it in 2 quarters since. The position peaked at $7.72K in Q1 2026. 27 funds tracked by Wall St. Rank hold SER as of Q2 2026.

  • Caitong International Asset Management held 3,744 shares of Serina Therapeutics worth $7.26K as of Q2 2026.
  • Caitong International Asset Management sold 238 Serina Therapeutics shares in Q2 2026, an estimated $447.
  • Serina Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1225 holding.
  • Caitong International Asset Management first reported a position in Serina Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Caitong International Asset Management's Serina Therapeutics position peaked at $7.72K in Q1 2026.
  • 27 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.